Application of the EIIP/ISM bioinformatics concept in development of new drugs.
about
Virtual screen for repurposing approved and experimental drugs for candidate inhibitors of EBOLA virus infectionIn Silico Prediction and Experimental Confirmation of HA Residues Conferring Enhanced Human Receptor Specificity of H5N1 Influenza A VirusesPrediction of intrinsically disordered regions in proteins using signal processing methods: application to heat-shock proteins.Novel phylogenetic algorithm to monitor human tropism in Egyptian H5N1-HPAIV reveals evolution toward efficient human-to-human transmission.In silico Therapeutics for Neurogenic Hypertension and Vasovagal Syncope.Characterization of conserved properties of hemagglutinin of H5N1 and human influenza viruses: possible consequences for therapy and infection control.New in silico and conventional in vitro approaches to advance HIV drug discovery and design.CISAPS: Complex Informational Spectrum for the Analysis of Protein Sequences.In silico analysis suggests repurposing of ibuprofen for prevention and treatment of EBOLA virus disease.DNABP: Identification of DNA-Binding Proteins Based on Feature Selection Using a Random Forest and Predicting Binding Residues.Cell-impedance-based label-free technology for the identification of new drugs.The role of long-range intermolecular interactions in discovery of new drugs.EL_PSSM-RT: DNA-binding residue prediction by integrating ensemble learning with PSSM Relation Transformation.G-protein-coupled receptor-based drugs rediscovered.Cytoplasmatic compartmentalization by Bcr-Abl promotes TET2 loss-of-function in chronic myeloid leukemia.Assessment of hepatitis C virus protein sequences with regard to interferon/ribavirin combination therapy response in patients with HCV genotype 1b.Feature-based classification of amino acid substitutions outside conserved functional protein domains.
P2860
Q28649882-E6D8EF33-F066-4874-BBA0-A923327C5ED9Q30375878-065A8BE4-838F-4D9C-BD8E-C0222A77A381Q30386377-114740BA-31D7-4834-9F9B-7A201B420F3DQ30430279-34A653E7-ADAF-4989-84C4-9F9000700605Q33166766-E944267A-571F-41A3-8A52-96D9080127A2Q33427655-443F7C43-A71D-4987-BAE1-5E5270F0588EQ34483539-A2C17336-E122-4B86-850C-F5CA86F24407Q34999522-8F391AE7-5C28-4C5A-8A2B-DDC41A65F323Q35689217-ED29EBFF-1280-4074-ADF6-F3938AEEE502Q36210279-E2D250D9-4328-41B6-81CB-3F89D003ADFEQ36301873-E4CC0FD5-8B2F-49F5-A542-1EBCA2DE2F22Q38014574-BF020E2D-DACC-4F42-8000-508834964362Q38603466-CF2B5105-C9F9-48D6-A3B0-24BE101DC75DQ38683811-D7F010E1-C007-4DD9-807B-47E79DB3F812Q39370931-6CE18923-DA55-402C-9111-074CFD481012Q43047642-A8080215-4472-460D-9537-4402DBB2B4CCQ51131904-58DAC9AD-A7D6-4269-B109-17EA3297BB32
P2860
Application of the EIIP/ISM bioinformatics concept in development of new drugs.
description
2007 nî lūn-bûn
@nan
2007 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Application of the EIIP/ISM bioinformatics concept in development of new drugs.
@ast
Application of the EIIP/ISM bioinformatics concept in development of new drugs.
@en
Application of the EIIP/ISM bioinformatics concept in development of new drugs.
@nl
type
label
Application of the EIIP/ISM bioinformatics concept in development of new drugs.
@ast
Application of the EIIP/ISM bioinformatics concept in development of new drugs.
@en
Application of the EIIP/ISM bioinformatics concept in development of new drugs.
@nl
prefLabel
Application of the EIIP/ISM bioinformatics concept in development of new drugs.
@ast
Application of the EIIP/ISM bioinformatics concept in development of new drugs.
@en
Application of the EIIP/ISM bioinformatics concept in development of new drugs.
@nl
P2093
P1476
Application of the EIIP/ISM bioinformatics concept in development of new drugs.
@en
P2093
P304
P356
10.2174/092986707779941014
P577
2007-01-01T00:00:00Z